ランセットの世界市場予測(~2024年)

【英語タイトル】Lancets Market by Type (Safety Lancets (Push button, Pressure Activated, Side Button), Personal Lancets), Application (Glucose Testing, Hemoglobin Testing), End User (Hospital, Clinic, Homecare), Region - Global Forecast to 2024

MarketsandMarketsが出版した調査資料(MD 7166)・商品コード:MD 7166
・発行会社(調査会社):MarketsandMarkets
・発行日:2019年6月17日
・ページ数:108
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥610,200見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥718,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥880,200見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、ランセットの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類(安全ランセット(プッシュボタン、圧力作動、再度ボタン)、パーソナルランセット別分析、用途(グルコース検査、ヘモグロビン検査)別分析、エンドユーザー(病院、クリニック、ホームケア)別分析、ランセットの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

“The lancets market is projected to grow at a CAGR of 12.4% during the forecast period (2019–2024).”The lancets market is projected to reach USD 1,442 million by 2024 from USD 804 million in 2019, at a CAGR of 12.4%. Market growth is attributed to the growing prevalence of diabetes and the high prevalence of infectious diseases. However, the risk of needlestick injuries and the poor reimbursement scenario in developing countries may restrain market growth.

“By type, the safety lancets segment is expected to grow at the highest CAGR during the forecast period.”

Based on type, the lancets market is segmented into safety and personal lancets. The safety lancets segment is expected to grow at the highest CAGR during the forecast period. This is mainly due to the benefits associated with safety lancets such as their ease of use, the capability to prevent needlestick injuries and cross-contamination, and painlessness of vein puncture.

“By end user, the hospitals and clinics segment to dominate the lancets market in 2019.”

On the basis of end user, the lancets market is segmented into hospitals and clinics, home care settings, and other end users. The hospitals and clinics segment is expected to hold the largest share of the lancets market in 2019. This is attributed to rising awareness about diabetes treatment and the increasing prevalence of infectious diseases that require blood testing.

“APAC is expected to witness the highest growth during the forecast period.”

North America is expected to account for the largest share of the lancets market in 2019, followed by Europe. The large share of the market in North America can majorly be attributed to the increasing prevalence of diabetes and the favorable reimbursement scenario in the region. However, the APAC region is expected to witness the highest CAGR during the forecast period. This can primarily be attributed to the growing healthcare industry, increasing geriatric population, rapid economic growth, and rising awareness about diabetes treatment.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–55%, Tier 2–25%, and Tier 3–20%
• By Designation: C-level–43%, Director-level–32%, and Others–25%
• By Region: North America–38%, Europe–23%, Asia Pacific–29%, Rest of the World–10%

The prominent players in the lancets market are Becton, Dickinson and Company (US), Roche Diagnostics (Switzerland), Ypsomed (Switzerland), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Own Mumford (UK), HTL-STREFA S.A (Poland), ARKRAY (Japan), Sarstedt (Germany), and SteriLance Medical (Suzhou) (China).

Research Coverage:
The report analyzes the lancets market and aims at estimating the market size and future growth potential of the lancets and the different segments by type, application, and end user. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the lancets market
• Product & Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product or service launches in the lancets market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products and services, growing geographies, and recent developments in the global lancets market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products & services of the leading players in the lancets market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 12
1.1 OBJECTIVES OF THE STUDY 12
1.2 MARKET DEFINITION 12
1.3 MARKET SCOPE 13
1.3.1 MARKETS COVERED 13
1.3.2 YEARS CONSIDERED FOR THE STUDY 13
1.4 CURRENCY 14
1.5 LIMITATIONS 14
1.6 STAKEHOLDERS 14
2 RESEARCH METHODOLOGY 15
2.1 RESEARCH DATA 15
2.1.1 SECONDARY DATA 17
2.1.1.1 Key data from secondary sources 17
2.1.2 PRIMARY DATA 18
2.1.2.1 Key data from primary sources 19
2.1.2.2 Key industry insights 20
2.2 MARKET SIZE ESTIMATION 20
2.2.1 MARKET DATA VALIDATION AND TRIANGULATION 22
2.3 ASSUMPTIONS FOR THE STUDY 23
3 EXECUTIVE SUMMARY 24
4 PREMIUM INSIGHTS 28
4.1 LANCETS MARKET OVERVIEW 28
4.2 NORTH AMERICA: LANCETS MARKET, BY TYPE, 2018 29
4.3 EUROPE: LANCETS MARKET, BY TYPE, 2018 30
4.4 LANCETS MARKET: GEOGRAPHIC SNAPSHOT 31
5 MARKET OVERVIEW 32
5.1 INTRODUCTION 32
5.2 MARKET DYNAMICS 32
5.2.1 DRIVERS 33
5.2.1.1 Growing prevalence of diabetes 33
5.2.1.2 High prevalence of infectious diseases 33
5.2.2 RESTRAINTS 33
5.2.2.1 Risk of needlestick injuries 33
5.2.2.2 Poor reimbursement scenario in developing countries 34

5.2.3 OPPORTUNITIES 34
5.2.3.1 High growth prospects in emerging countries 34
5.2.4 CHALLENGES 35
5.2.4.1 Reuse of lancets 35
6 LANCETS MARKET, BY TYPE 36
6.1 INTRODUCTION 37
6.2 SAFETY LANCETS 38
6.2.1 PUSH-BUTTON LANCETS 39
6.2.1.1 Ease of use and simplicity have driven demand for push-button lancets 39
6.2.2 PRESSURE-ACTIVATED LANCETS 39
6.2.2.1 These lancets are available in a number of gauge sizes and penetration depths 39
6.2.3 SIDE-BUTTON LANCETS 40
6.2.3.1 Ease of use and anti-reuse measures have made side-button lancets popular among end users 40
6.3 PERSONAL LANCETS 41
6.3.1 INCREASING PREVALENCE OF DIABETES HAS RESULTED IN SIGNIFICANT DEMAND FOR PERSONAL LANCETS 41
7 LANCETS MARKET, BY APPLICATION 42
7.1 INTRODUCTION 43
7.2 GLUCOSE TESTING 44
7.2.1 INCREASING DIABETES PREVALENCE IS EXPECTED TO DRIVE THE DEMAND FOR LANCETS IN GLUCOSE TESTING DURING THE FORECAST PERIOD 44
7.3 HEMOGLOBIN TESTING 45
7.3.1 HIGH PREVALENCE OF ANEMIA EXPECTED TO INCREASE HEMOGLOBIN TESTING VOLUME AND THE DEMAND FOR LANCETS 45
7.4 COAGULATION TESTING 45
7.4.1 RISING PREVALENCE OF LIVER DISEASES, THROMBOPHILIA, AND HEMOPHILIA TO DRIVE THE DEMAND FOR COAGULATION TESTING 45
7.5 OTHER APPLICATIONS 46
7.5.1 THIS SEGMENT COVERS OTHER APPLICATIONS OF LANCETS, SUCH AS PREGNANCY TESTING, INFECTIOUS DISEASES TESTING, AND CHOLESTEROL TESTING. 46
8 LANCETS MARKET, BY END USER 48
8.1 INTRODUCTION 49
8.2 HOSPITALS & CLINICS 50
8.2.1 INCREASING INCIDENCE OF DISEASES THAT REQUIRE BLOOD TESTING FOR DIAGNOSIS AND TREATMENT IS DRIVING THE ADOPTION OF LANCETS IN HOSPITALS AND CLINICS 50

8.3 HOME CARE SETTINGS 51
8.3.1 INCREASING PREVALENCE OF DIABETES IS EXPECTED TO DRIVE THE DEMAND FOR LANCETS IN THE HOME CARE SETTINGS SEGMENT DURING THE FORECAST PERIOD 51
8.4 OTHER END USERS 52
9 LANCETS MARKET, BY REGION 53
9.1 INTRODUCTION 54
9.2 NORTH AMERICA 54
9.2.1 HIGH DIABETIC POPULATION AND REIMBURSEMENT COVERAGE FOR LANCETS WILL DRIVE MARKET GROWTH IN NORTH AMERICA 54
9.3 EUROPE 57
9.3.1 RISING AWARENESS ON DIABETES TREATMENT AND PREVENTION WILL CONTRIBUTE TO LANCET USE IN EUROPE 57
9.4 ASIA PACIFIC 60
9.4.1 RAPID ECONOMIC GROWTH IN APAC COUNTRIES WILL PROVIDE OPPORTUNITIES FOR MARKET PLAYERS 60
9.5 ROW 77
10 COMPETITIVE LANDSCAPE 79
10.1 OVERVIEW 79
10.2 COMPETITIVE LEADERSHIP MAPPING (2018) 79
10.2.1 VENDOR INCLUSION CRITERIA 79
10.2.2 VISIONARY LEADERS 79
10.2.3 INNOVATORS 79
10.2.4 DYNAMIC DIFFERENTIATORS 79
10.2.5 EMERGING COMPANIES 80
11 COMPANY PROFILES 81
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 BECTON, DICKINSON AND COMPANY 81
11.2 ROCHE DIAGNOSTICS 83
11.3 YPSOMED 85
11.4 B. BRAUN MELSUNGEN 87
11.5 TERUMO CORPORATION 89
11.6 OWEN MUMFORD 91
11.7 HTL-STREFA S.A 92
11.8 ARKRAY 94
11.9 SARSTEDT 95
11.10 STERILANCE MEDICAL (SUZHOU) 96
11.11 MEDLINE INDUSTRIES 97
11.12 INTRINSYK 98
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
12 APPENDIX 99
12.1 DISCUSSION GUIDE 99
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 104
12.3 AVAILABLE CUSTOMIZATIONS 106
12.4 RELATED REPORTS 106
12.5 AUTHOR DETAILS 107

LIST OF TABLES

TABLE 1 INCIDENCE OF INFECTIOUS DISEASES 33
TABLE 2 LANCETS MARKET, BY TYPE, 2017–2024 (USD BILLION) 37
TABLE 3 SAFETY LANCETS MARKET, BY REGION, 2017–2024 (USD MILLION) 38
TABLE 4 SAFETY LANCETS MARKET, BY TYPE, 2017–2024 (USD MILLION) 38
TABLE 5 PUSH-BUTTON LANCETS MARKET, BY REGION, 2017–2024 (USD MILLION) 39
TABLE 6 PRESSURE-ACTIVATED LANCETS MARKET, BY REGION, 2017–2024 (USD MILLION) 40
TABLE 7 SIDE-BUTTON LANCETS MARKET, BY REGION, 2017–2024 (USD MILLION) 40
TABLE 8 PERSONAL LANCETS MARKET, BY REGION, 2017–2024 (USD MILLION) 41
TABLE 9 LANCETS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 43
TABLE 10 LANCETS MARKET FOR GLUCOSE TESTING, BY REGION,
2017–2024 (USD MILLION) 44
TABLE 11 LANCETS MARKET FOR HEMOGLOBIN TESTING, BY REGION,
2017–2024 (USD MILLION) 45
TABLE 12 LANCETS MARKET FOR COAGULATION TESTING, BY REGION,
2017–2024 (USD MILLION) 46
TABLE 13 LANCETS MARKET FOR OTHER APPLICATIONS, BY REGION,
2017–2024 (USD MILLION) 47
TABLE 14 LANCETS MARKET, BY END USER, 2017–2024 (USD MILLION) 49
TABLE 15 LANCETS MARKET FOR HOSPITALS & CLINICS, BY REGION,
2017–2024 (USD MILLION) 50
TABLE 16 LANCETS MARKET FOR HOME CARE SETTINGS, BY REGION,
2017–2024 (USD MILLION) 51
TABLE 17 LANCETS MARKET FOR OTHER END USERS, BY REGION,
2017–2024 (USD MILLION) 52
TABLE 18 LANCETS MARKET, BY REGION, 2017–2024 (USD MILLION) 54
TABLE 19 NORTH AMERICA: LANCETS MARKET, BY TYPE, 2017–2024 (USD MILLION) 56
TABLE 20 NORTH AMERICA: SAFETY LANCETS MARKET, BY TYPE, 2017–2024 (USD MILLION) 56
TABLE 21 NORTH AMERICA: LANCETS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 56
TABLE 22 NORTH AMERICA: LANCETS MARKET, BY END USER, 2017–2024 (USD MILLION) 57
TABLE 23 EUROPE: LANCETS MARKET, BY TYPE, 2017–2024 (USD MILLION) 58
TABLE 24 EUROPE: SAFETY LANCETS MARKET, BY TYPE, 2017–2024 (USD MILLION) 58
TABLE 25 EUROPE: LANCETS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 59
TABLE 26 EUROPE: LANCETS MARKET, BY END USER, 2017–2024 (USD MILLION) 59
TABLE 27 APAC: LANCETS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 62
TABLE 28 APAC: LANCETS MARKET, BY TYPE, 2017–2024 (USD MILLION) 62
TABLE 29 APAC: SAFETY LANCETS MARKET, BY TYPE, 2017–2024 (USD MILLION) 62
TABLE 30 APAC: LANCETS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 63
TABLE 31 APAC: LANCETS MARKET, BY END USER, 2017–2024 (USD MILLION) 63
TABLE 32 CHINA: LANCETS MARKET, BY TYPE, 2017–2024 (USD MILLION) 63
TABLE 33 CHINA: SAFETY LANCETS MARKET, BY TYPE, 2017–2024 (USD MILLION) 64
TABLE 34 CHINA: LANCETS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 64
TABLE 35 CHINA: LANCETS MARKET, BY END USER, 2017–2024 (USD MILLION) 64
TABLE 36 AUSTRALIA: LANCETS MARKET, BY TYPE, 2017–2024 (USD MILLION) 65
TABLE 37 AUSTRALIA: SAFETY LANCETS MARKET, BY TYPE, 2017–2024 (USD MILLION) 65
TABLE 38 AUSTRALIA: LANCETS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 65
TABLE 39 AUSTRALIA: LANCETS MARKET, BY END USER, 2017–2024 (USD MILLION) 66
TABLE 40 SOUTH KOREA: LANCETS MARKET, BY TYPE, 2017–2024 (USD MILLION) 66
TABLE 41 SOUTH KOREA: SAFETY LANCETS MARKET, BY TYPE,
2017–2024 (USD THOUSAND) 66
TABLE 42 SOUTH KOREA: LANCETS MARKET, BY APPLICATION,
2017–2024 (USD THOUSAND) 67
TABLE 43 SOUTH KOREA: LANCETS MARKET, BY END USER, 2017–2024 (USD MILLION) 67
TABLE 44 INDONESIA: LANCETS MARKET, BY TYPE, 2017–2024 (USD MILLION) 68
TABLE 45 INDONESIA: SAFETY LANCETS MARKET, BY TYPE, 2017–2024 (USD THOUSAND) 68
TABLE 46 INDONESIA: LANCETS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND) 68
TABLE 47 INDONESIA: LANCETS MARKET, BY END USER, 2017–2024 (USD MILLION) 69
TABLE 48 MALAYSIA: LANCETS MARKET, BY TYPE, 2017–2024 (USD MILLION) 69
TABLE 49 MALAYSIA: SAFETY LANCETS MARKET, BY TYPE, 2017–2024 (USD THOUSAND) 69
TABLE 50 MALAYSIA: LANCETS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND) 70
TABLE 51 MALAYSIA: LANCETS MARKET, BY END USER, 2017–2024 (USD MILLION) 70
TABLE 52 THAILAND: LANCETS MARKET, BY TYPE, 2017–2024 (USD MILLION) 70
TABLE 53 THAILAND: SAFETY LANCETS MARKET, BY TYPE, 2017–2024 (USD THOUSAND) 71
TABLE 54 THAILAND: LANCETS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND) 71
TABLE 55 THAILAND: LANCETS MARKET, BY END USER, 2017–2024 (USD THOUSAND) 71
TABLE 56 VIETNAM: LANCETS MARKET, BY TYPE, 2017–2024 (USD THOUSAND) 72
TABLE 57 VIETNAM: SAFETY LANCETS MARKET, BY TYPE, 2017–2024 (USD THOUSAND) 72
TABLE 58 VIETNAM: LANCETS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND) 72
TABLE 59 VIETNAM: LANCETS MARKET, BY END USER, 2017–2024 (USD THOUSAND) 73
TABLE 60 SINGAPORE: LANCETS MARKET, BY TYPE, 2017–2024 (USD THOUSAND) 73
TABLE 61 SINGAPORE: SAFETY LANCETS MARKET, BY TYPE, 2017–2024 (USD THOUSAND) 73
TABLE 62 SINGAPORE: LANCETS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND) 74
TABLE 63 SINGAPORE: LANCETS MARKET, BY END USER, 2017–2024 (USD THOUSAND) 74
TABLE 64 NEW ZEALAND: LANCETS MARKET, BY TYPE, 2017–2024 (USD THOUSAND) 74
TABLE 65 NEW ZEALAND: SAFETY LANCETS MARKET, BY TYPE,
2017–2024 (USD THOUSAND) 75
TABLE 66 NEW ZEALAND: LANCETS MARKET, BY APPLICATION,
2017–2024 (USD THOUSAND) 75
TABLE 67 NEW ZEALAND: LANCETS MARKET, BY END USER, 2017–2024 (USD THOUSAND) 75
TABLE 68 ROAPAC: LANCETS MARKET, BY TYPE, 2017–2024 (USD MILLION) 76
TABLE 69 ROAPAC: SAFETY LANCETS MARKET, BY TYPE, 2017–2024 (USD MILLION) 76
TABLE 70 ROAPAC: LANCETS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 76
TABLE 71 ROAPAC: LANCETS MARKET, BY END USER, 2017–2024 (USD MILLION) 77
TABLE 72 ROW: LANCETS MARKET, BY TYPE, 2017–2024 (USD MILLION) 77
TABLE 73 ROW: SAFETY LANCETS MARKET, BY TYPE, 2017–2024 (USD MILLION) 78
TABLE 74 ROW: LANCETS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 78
TABLE 75 ROW: LANCETS MARKET, BY END USER, 2017–2024 (USD MILLION) 78


LIST OF FIGURES

FIGURE 1 LANCETS MARKET 13
FIGURE 2 LANCETS MARKET: RESEARCH METHODOLOGY 15
FIGURE 3 RESEARCH DESIGN 16
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 19
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 21
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 21
FIGURE 7 DATA TRIANGULATION METHODOLOGY 22
FIGURE 8 LANCETS MARKET, BY TYPE, 2019–2024 24
FIGURE 9 LANCETS MARKET, BY APPLICATION, 2019 25
FIGURE 10 LANCETS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION) 26
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE LANCETS MARKET 26
FIGURE 12 INCREASING INCIDENCE DIABETES TO DRIVE THE GROWTH OF
THE LANCETS MARKET 28
FIGURE 13 SAFETY LANCETS HELD LARGEST SHARE OF THE NORTH AMERICAN
MARKET, 2018 29
FIGURE 14 PUSH-BUTTON LANCETS TO DOMINATE THE EUROPEAN MARKET DURING THE FORECAST PERIOD 30
FIGURE 15 ASIA PACIFIC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 31
FIGURE 16 LANCETS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES 32
FIGURE 17 SAFETY LANCETS TO WITNESS THE HIGHEST GROWTH IN THE LANCETS MARKET FROM 2019 TO 2024 37
FIGURE 18 GLUCOSE TESTING WAS THE LARGEST APPLICATION SEGMENT IN THE LANCETS MARKET IN 2018 43
FIGURE 19 LANCETS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION) 49
FIGURE 20 NORTH AMERICA: LANCETS MARKET SNAPSHOT 55
FIGURE 21 ASIA PACIFIC: LANCETS MARKET SNAPSHOT 61
FIGURE 22 MNM DIVE-VENDOR COMPARISON MATRIX: LANCETS MARKET 80
FIGURE 23 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 81
FIGURE 24 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT 83
FIGURE 25 YPSOMED: COMPANY SNAPSHOT 85
FIGURE 26 B.BRAUN: COMPANY SNAPSHOT 87
FIGURE 27 TERUMO CORPORATION: COMPANY SNAPSHOT 89


★調査レポート[ランセットの世界市場予測(~2024年)] (コード:MD 7166)販売に関する免責事項を必ずご確認ください。
★調査レポート[ランセットの世界市場予測(~2024年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆